Please login to the form below

A new vision for tackling key illnesses

Steve How and Oli Hudson, of Wilmington Healthcare, explore the NHS Long-term Plan’s strategy for delivering more preventative, joined-up services for major health conditions


The Long-term Plan furthers the NHS Five Year Forward View’s focus on cancer, mental health, diabetes, multimorbidity and healthy ageing. It also looks at other areas, such as cardiovascular and respiratory conditions, and explains how the NHS plans to change its approach in order to drive improvements in patient care and outcomes.  

Cardiovascular disease (CVD

Cardiovascular disease (CVD) has been identified in the Long-term Plan as “the single biggest area where the NHS can save lives over the next 10 years”. Detecting patients at risk of CVD and preventing the disease from occurring will be key to helping the NHS achieve its ambition.

In line with this, pharmacists and nurses in Primary Care Networks (PCNs) will be supported in identifying and treating relevant cohorts of patients. There will be a big focus on lifestyle improvements for at-risk patients, particularly weight management, as well as social prescribing. A new national CVD prevention audit will feed into the above activities.

There will also be a major structural change in stroke services, where hyper acute specialist stroke centres with new clot busting technology will be replacing existing stroke-receiving units.


The NHS plans to double the size of the NHS Diabetes Prevention Programme for type 2 diabetes. As with other disease areas, there will be a big emphasis on engaging patients in managing their health and also on disease prevention. Aligned with this weight management services will be critical, particularly in light of recent studies which have shown that if patients lose weight rapidly and significantly, it is possible to go into remission for type 2 diabetes.

The Long-term Plan shows how technology will help to move diabetes services out of hospitals and support self-care. For example, newly diagnosed patients will be offered expanding provision of structured education and digital self-management support tools including HeLP Diabetes - an online self-management tool for those with type 2 diabetes.


The NHS aims to increase the number of cancer diagnoses at stage one and two from 50 percent of patients now to 75 percent by 2028. Changes will include modernising the Bowel Cancer Screening Programme and making the Faecal Immunochemical Test for haemoglobin easier for patients to use. The NHS will also implement HPV primary screening for cervical cancer across England by 2020.

The NHS plans to introduce a new faster diagnosis standard from 2020 to ensure that most patients receive a definitive diagnosis or ruling out of cancer within 28 days of referral from a GP or from screening.

The new diagnosis standard will be underpinned by a radical overhaul of the way diagnostic services are delivered for patients with suspected cancer. Starting this year, new Rapid Diagnostic Centres (RDCs) will be rolled out across the country to upgrade and bring together the latest diagnostic equipment and expertise. Cancer Alliances will also work with Integrated Care Systems (ICSs) to aid swift access to a consultant’s opinion.

Respiratory conditions

The NHS will build on the existing NHS RightCare programme to reduce variation across the country in the quality of spirometry testing, which is a key test for lung function. PCNs will support the diagnosis of respiratory conditions; while more staff in primary care will be trained and accredited to interpret test results.

Pulmonary rehabilitation, which involves activities such as breathing exercises and learning how to cope in an emergency, is one of the most expensive elements of the respiratory pathway. It will be run by multi-disciplinary teams using digital tools, such as My COPD, which is a toolkit for Clinical Commissioning Groups (CCGs).

Pharmacists will play a big role in managing respiratory care in PCNs. This will include medication reviews, educating patients and also advising on the use of inhalers – a critical task given that 90 percent of people use their inhaler incorrectly, according to the NHS.

Mental health

In the Long-term Plan, the NHS makes a new commitment to funding mental health services for children and young people, and pledges that this area will grow faster than both overall NHS funding and total mental health spending.

There is also a realisation that children’s mental health goes beyond the NHS; hence we expect to see multidisciplinary teams working in schools as the first point of contact for pupils.

The NHS promises to continue to expand access to IAPT services for adults and older adults with common mental health problems, with a focus on those with long-term conditions.

Digital services, such as mobile apps, are expected to play a big part in delivery and access to mental healthcare services, especially for children and young people.


While the detail varies in each health condition, there are many common themes, particularly with regards to illness prevention and the associated need to risk stratify patients; engage them in their treatment and encourage them to make lifestyle changes, where appropriate.

There is also a desire to deliver many services for these conditions in the community via integrated teams in PCNs. Consequently, it will be essential for pharma to think about how its products can deliver benefits across the whole care system and to determine how it can support the NHS in delivering more holistic, preventative care services.


Steve How and Oli Hudson are part of Wilmington Healthcare’s Consulting Team. For information on Wilmington Healthcare, visit

11th June 2019



Company Details

Wilmington Healthcare

01268 495600

Contact Website

Beechwood House
2-3 Commercial Way
Christy Close
SS15 6EF
United Kingdom

Latest content on this profile

We must be candid about our use of healthcare data if we want to win back public trust
As the government announces a delay to a new GP data sharing initiative amid privacy concerns, Gareth Thomas, Managing Director of Wilmington Healthcare, explains why industry must move fast to rebuild public confidence.
Wilmington Healthcare
Wilmington Healthcare appoints new Solutions Director
Kirsty Fryer has been promoted to the role of Solutions Director for Wilmington Healthcare
Wilmington Healthcare
Understanding the role of provider collaboratives
Oli Hudson, Content Director at Wilmington Healthcare, takes a look at the new groups of providers that are expected to play a pivotal role in integrating care.
Wilmington Healthcare
How does the government plan to reshape the NHS?
Oli Hudson, of Wilmington Healthcare, explores the government’s new white paper, which proposes key reforms for health and social care
Wilmington Healthcare
Integrated NHS finances: what do they mean for High Cost Drugs?
Oli Hudson and Steve How, of Wilmington Healthcare, explore NHS England’s new system-level funding and its impact on prescribing for High Cost Drugs
Wilmington Healthcare
Covid-19: how is it affecting prescribing patterns?
Oli Hudson, Content Director at Wilmington Healthcare, analyses prescribing data in three key disease areas
Wilmington Healthcare